Insider trading

Period: 120 months Stock: AORT + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

267 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

267 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

267 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

267 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
267 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
267 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

267 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
3 May 2018
Davis John E Senior VP, Global Sales
Sold, plan not stated
$80.02K 3,334 at 24.00
6.1%
3 May 2018
RONALD C ELKINS Director
Sold, plan not stated
$48.00K 2,000 at 24.00
2.0%
17 Apr 2018
Davis John E Senior VP, Global Sales
Sold, plan not stated
$76.66K 3,333 at 23.00
6.1%
8 Mar 2018
McCall Ronald D Director
Sold, plan not stated
$105.45K 5,000 at 21.09
3.3%
8 Mar 2018
RONALD C ELKINS Director
Sold, plan not stated
$44.00K 2,000 at 22.00
2.0%
15 Dec 2017
RONALD C ELKINS Director
Sold, plan not stated
$20.00K 1,000 at 20.00
1.0%
16 Nov 2017
Gale David C VP, Research & Development
Sold, plan not stated 2×
$392.50K 20,000 at 19.63
20.6%
9 Nov 2017
LEE DAVID ASHLEY Executive VP, COO & CFO
Sold, plan not stated
$559.89K 30,143 at 18.57
9.4%
8 Nov 2017
LEE DAVID ASHLEY Executive VP, COO & CFO
Sold, plan not stated
$630.55K 33,190 at 19.00
10.2%
8 Nov 2017
Horton Amy VP, Chief Accounting Officer
Sold, plan not stated
$76.00K 4,000 at 19.00
3.9%
6 Nov 2017
RONALD C ELKINS Director
Sold, plan not stated
$19.03K 1,000 at 19.03
1.0%
2 Oct 2017
Benson James Director
Sold, plan not stated
$45.60K 2,000 at 22.80
3.6%
6 Sep 2017
Mackin James P President & CEO
Sold, plan not stated
$1.80M 81,950 at 21.97
20.6%
5 Sep 2017
Mackin James P President & CEO
Sold, plan not stated
$951.06K 43,050 at 22.09
9.8%
5 Sep 2017
RONALD C ELKINS Director
Sold, plan not stated
$22.00K 1,000 at 22.00
1.0%
27 Jun 2017
Horton Amy VP, Chief Accounting Officer
Sold, plan not stated
$191.54K 9,577 at 20.00
8.5%
22 Feb 2017
Capps Scott B VP, Clinical Research
Sold, plan not stated
$181.78K 11,083 at 16.40
8.6%
Showing 251–267 of 267. ← Newer Page 6 of 6